Rutin, a flavanol, exerts protective effect against cellular senescence in rats via its senotherapeutic activity

Published: 23 June 2026| Version 1 | DOI: 10.17632/fxhpyg6jys.1
Contributors:
,
,
,
,
,

Description

This study investigated the senotherapeutic potential of Rutin in an accelerated senescence model of male Wistar rats based upon parameters linked to suppression of senescence-associated secretory phenotype (SASP), senescence-associated β-galactosidase (SA-β-Gal) activity assay, and modulation of oxidative stress. Accelerated senescence was induced by chronic D-Galactose administration (300mg/kg body weight), and rats were divided into control, Rutin-supplemented, D-Galactose, and Rutin + D-Galactose groups. Treatment of Rutin (100mg/kg body weight) for 28 days significantly suppressed SASP, which includes cytokines such as IL-6 and TNFα, and showed a decline in the number of senescent cells as confirmed by the SA-β-gal assay. Rutin administration also lowered oxidative stress markers, restored antioxidant enzyme activities, and lowered sialic acid levels compared to the D-Galactose-treated group. These results indicate that Rutin mitigates D-Galactose-induced senescence and oxidative damage, highlighting its potential as a senotherapeutic that may delay age-related functional decline.

Files

Institutions

Categories

Biochemical Assay

Licence